Blair William & CO Organon & Co. Transaction History

Blair William & CO

$31.4 Billion
Q1 2024

A detailed history of Blair William & CO transactions in Organon & Co. stock. As of the latest transaction made, Blair William & CO holds 14,522 shares of OGN stock, worth $292,182. This represents 0.0% of its overall portfolio holdings.

Number of Shares

14,522

Previous 16,442 11.68%

Holding current value

$292,182

Previous $237,000 15.19%

% of portfolio

0.0%

Previous 0.0%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 09, 2024	SELL	$13.78 - $18.8 $26,457 - $36,096	-1,920 Reduced 11.68%	14,522 $273,000
Q4 2023 Feb 12, 2024	SELL	$10.95 - $17.32 $17,728 - $28,041	-1,619 Reduced 8.96%	16,442 $237,000
Q3 2023 Nov 09, 2023	SELL	$16.59 - $23.77 $13,321 - $19,087	-803 Reduced 4.26%	18,061 $313,000
Q2 2023 Aug 11, 2023	SELL	$19.27 - $24.63 $16,803 - $21,477	-872 Reduced 4.42%	18,864 $392,000
Q1 2023 May 12, 2023	SELL	$21.42 - $32.08 $386,459 - $578,787	-18,042 Reduced 47.76%	19,736 $464,000

Q4 2022 Feb 10, 2023	BUY	$23.31 - $28.61 $241,165 - $295,999	10,346 Added 37.72%	37,778 $1.06 Million
Q3 2022 Nov 09, 2022	BUY	$23.4 - $34.25 $16,824 - $24,625	719 Added 2.69%	27,432 $642,000
Q2 2022 Aug 10, 2022	SELL	$31.66 - $38.9 $35,269 - $43,334	-1,114 Reduced 4.0%	26,713 $902,000
Q1 2022 May 13, 2022	SELL	$30.45 - $39.36 $216,134 - $279,377	-7,098 Reduced 20.32%	27,827 $972,000
Q4 2021 Feb 14, 2022	BUY	$28.67 - $37.13 $124,513 - $161,255	4,343 Added 14.2%	34,925 $1.06 Million
Q3 2021 Nov 12, 2021	SELL	$28.63 - $35.64 $465,266 - $579,185	-16,251 Reduced 34.7%	30,582 $1 Million
Q2 2021 Aug 12, 2021	BUY	$28.45 - $38.0 $1.33 Million - $1.78 Million	46,833 New	46,833 $1.42 Million

Others Institutions Holding OGN

# of Institutions

786

Shares Held

190M

Call Options Held

2.46M

Put Options Held

2.27M

View Full List

About Organon & Co.

Ticker OGN
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 254,330,000
Market Cap $5.12B
Description
Organon & Co., a health care company, develops and delivers health solutions through a portfolio of prescription therapies in the United States and internationally. Its women's health portfolio comprises contraception and fertility brands, such as Nexplanon/Implanon, a long-acting reversible contraceptive. The company's biosimilars portfolio...

More about OGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Blair William & CO, based on Form 13F filings with the SEC.

News

Stay updated on Blair William & CO with notifications on news.

Account